文献速递乳腺乳腺X线USMR

患者主动发起的亚专科复核对患者诊疗的影响

The Impact of Patient-Initiated Subspecialty Review on Patient Care.
PubMed 文献 · J Am Coll Radiol · 2018-06-28

该回顾性研究纳入245例自我转诊寻求乳腺影像二次意见的患者中的147例共176个病灶,比较原始解读与亚专科二次意见解读,并以病理或随访影像为参考标准。二次意见与原始解读不一致的病灶占47%,将25%原判为可疑的病灶降级从而避免活检,将39%原判为良性或可能良性的病灶升级为可疑,二次意见建议的活检中29%检出癌症。

要点

  • 二次意见与原始解读不一致的病灶占47%(82/176),提示亚专科复核可显著改变判读。
  • 二次意见将25%(24/96)原判可疑病灶降级为良性或可能良性,避免了这些病灶的活检。
  • 二次意见将39%(31/80)原判良性或可能良性病灶升级为可疑。

核心结论

  • 对于寻求乳腺影像专家意见的患者,即使尚未诊断为乳腺癌,二次意见复核也有价值;二次意见与原始解读不一致的病灶占47%,避免了25%原建议的活检,并在29%的额外建议活检中检出癌症;二次意见后诊断的癌症中35%为原始解读未初次检出。

研究设计与样本

  • 经机构审查委员会批准的回顾性研究,纳入2014年提交至作者癌症中心行二次意见复核的415例乳腺影像检查(来自245例患者),排除无随访或原始BI-RADS 0评估无变化的病例,最终纳入147例患者共176个病灶;以组织病理学或随访影像为参考标准,比较原始与二次意见的解读及建议。

诊断标准与关键数值

  • 原始解读中176个病灶有96个(55%)报告为可疑;二次意见与原始解读不一致的病灶为82/176(47%)。
  • 二次意见将原判可疑的96个病灶中的24个(25%)降级为良性或可能良性。
  • 二次意见将原判良性或可能良性的80个病灶中的31个(39%)升级为可疑。
  • 87个病灶接受了活检,其中23个(26%)活检结果为恶性;87次活检中28次(32%)为二次意见后建议,这28次中8次(29%)检出癌症。
  • 检出的23个癌症中8个(35%)为原始解读未初次检出的恶性病变。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine the effect of subspecialty review of breast imaging on patients without a diagnosis of breast cancer who self-referred for a second opinion.

METHODS: Institutional review board-approved retrospective review was performed of 415 breast imaging studies submitted to our cancer center for second-opinion review by 245 patients in 2014, excluding cases without follow-up or change in original BI-RADS 0 assessment. One hundred forty-seven patients with 176 lesions were included. Original and second-opinion interpretations and recommendations were compared with histopathology or follow-up imaging.

RESULTS: Ninety-six of 176 (55%) lesions were reported as suspicious in the original interpretation. Second-opinion review was discordant with the original interpretation in 82 of 176 (47%) lesions. Second-opinion review downgraded 24 of 96 (25%) lesions originally reported as suspicious to benign or probably benign, averting biopsy of these lesions. Second-opinion review upgraded 31 of 80 (39%) lesions originally reported as benign or probably benign to suspicious. A total of 87 lesions were biopsied yielding malignancy in 23 (26%) biopsies. Twenty-eight of 87 (32%) biopsies performed were recommended after second-opinion review, with 8 of 28 (29%) of these biopsies yielding cancer. Eight of 23 (35%) cancers detected represented malignancy not initially detected in the original interpretation.

CONCLUSION: Second-opinion review is valuable in patients pursuing a breast imaging specialist's opinion, even before they are diagnosed with breast cancer. Second-opinion review disagreed with the original interpretation for 47% of lesions, averted 25% of originally recommended biopsies, and detected cancer in 29% of additional biopsies recommended. Thirty-five percent of cancers diagnosed after second-opinion review were not initially detected in the original interpretation.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Coffey K, Mango V, Keating DM, et al. The Impact of Patient-Initiated Subspecialty Review on Patient Care. J Am Coll Radiol. 2018. PMID: 30078435. doi:10.1016/j.jacr.2018.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。